The reported statements, read against the company's own industry.
Financials view
Market Capitalization
10.51BCNY
1.58B · vs all stocks (USD)
Updated Oct 23, 2026
Revenue (TTM)
3.22BCNY
482.95M · vs all stocks (USD)
Updated Oct 23, 2026
Profit Margin
-8.00%
Updated Oct 23, 2026
Beta
0.2490x
vs all stocks
Updated Oct 23, 2026
52-Week Change
-6.33%
vs all stocks
Updated Oct 23, 2026
Market Capitalization
10.51BCNY
1.58B · vs all stocks (USD)
Updated Oct 23, 2026
Enterprise Value
39.20BCNY
5.88B · vs all stocks (USD)
Updated Oct 23, 2026
Forward P/E
8.61x
Updated Oct 23, 2026
Price to Sales (TTM)
3.26x
Updated Oct 23, 2026
Price to Book (MRQ)
1.29x
Updated Oct 23, 2026
Enterprise to Revenue
12.17x
Updated Oct 23, 2026
Enterprise to EBITDA
15.36x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 24.6×.Updated Oct 23, 2026
Gross Margin
41.57%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 44.87%.Updated Oct 23, 2026
Profit Margin
-8.00%
Updated Oct 23, 2026
Operating Margin
43.26%
Updated Oct 23, 2026
Return on Assets (TTM)
1.78%
Updated Oct 23, 2026
Return on Equity (TTM)
-2.40%
Updated Oct 23, 2026
Revenue (TTM)
3.22BCNY
482.95M · vs all stocks (USD)
Updated Oct 23, 2026
Revenue per Share (TTM)
1.58CNYUpdated Oct 23, 2026
Quarterly Revenue Growth
-11.70%
Updated Oct 23, 2026
Gross Profit (TTM)
1.45BCNY
216.70M · vs all stocks (USD)
Updated Oct 23, 2026
EBITDA (TTM)
1.59BCNY
238.90M · vs all stocks (USD)
Updated Oct 23, 2026
Net Income (TTM)
-257.61MCNY
-38.62M · vs all stocks (USD)
Updated Oct 23, 2026
Quarterly Earnings Growth (YoY)
-68.70%
Updated Oct 23, 2026
Operating Cash Flow (TTM)
2.58BCNY
386.19M · vs all stocks (USD)
Updated Oct 23, 2026
Levered Free Cash Flow (TTM)
736.13MCNY
110.37M · vs all stocks (USD)
Updated Oct 23, 2026
Payout Ratio
400.00%
Updated Oct 23, 2026
Minority Interest (Equity)
1.81BCNYFY2025 · Dec 31, 2025
Revenue
3.45BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
1.71BCNYFY2025 · Dec 31, 2025
Gross Profit
1.74BCNYFY2025 · Dec 31, 2025
Operating Income
1.46BCNY
218.45M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
300.10MCNYFY2025 · Dec 31, 2025
Income Tax Expense
215.12MCNYFY2025 · Dec 31, 2025
Net Income
84.98MCNYFY2025 · Dec 31, 2025
EBIT
1.10BCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
3.15BCNYFY2025 · Dec 31, 2025
Research & Development
12.51MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
77.29MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
38.60MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
1.71MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
803.84MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.0500CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.0500CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
2.03BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
2.03BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
84.98MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
16.28MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
1.92BCNYFY2025 · Dec 31, 2025
Free Cash Flow
338.35MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
983.43MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
84.98MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
841.81MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
937.37MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
55.18MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-1.58BCNYFY2025 · Dec 31, 2025
Net Acquisitions
-139.12MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-3.36BCNYFY2025 · Dec 31, 2025
Sale of Investments
3.35BCNYFY2025 · Dec 31, 2025
Other Investing Activity
11.50MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-1.72BCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
8.89BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-8.96BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-1.30BCNYFY2025 · Dec 31, 2025
Other Financing Charges
947.82MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-414.15MCNYFY2025 · Dec 31, 2025
Shares Outstanding
1.97BSharesUpdated Oct 23, 2026
Float Shares
1.59BSharesUpdated Oct 23, 2026
% Held by Insiders
18.80%
vs all stocks
Updated Oct 23, 2026
% Held by Institutions
17.46%
vs all stocks
Updated Oct 23, 2026
Total Cash (MRQ)
1.15BCNY
172.11M · vs all stocks (USD)
Updated Oct 23, 2026
Total Cash per Share (MRQ)
0.5440CNYUpdated Oct 23, 2026
Total Debt (MRQ)
27.10BCNY
4.06B · vs all stocks (USD)
Updated Oct 23, 2026
Total Debt to Equity (MRQ)
2.56x
Updated Oct 23, 2026
Current Ratio (MRQ)
2.04x
Updated Oct 23, 2026
Book Value per Share (MRQ)
4.14CNYUpdated Oct 23, 2026
Total Assets
39.33BCNY
5.90B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
9.55BCNYFY2025 · Dec 31, 2025
Total Liabilities
28.48BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
29.78BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
23.46BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
5.02BCNYFY2025 · Dec 31, 2025
Cash
983.43MCNYFY2025 · Dec 31, 2025
Cash Equivalents
12.50MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
995.93MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
346.05MCNYFY2025 · Dec 31, 2025
Accounts Receivable
7.37BCNYFY2025 · Dec 31, 2025
Inventory
5.71MCNYFY2025 · Dec 31, 2025
Accounts Payable
529.12MCNYFY2025 · Dec 31, 2025
Short-term Debt
2.50BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
53.43MCNYFY2025 · Dec 31, 2025
Long-term Debt
23.45BCNYFY2025 · Dec 31, 2025
Common Stock (Book)
2.00BCNYFY2025 · Dec 31, 2025
Retained Earnings
1.26BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
10.85BCNY
1.63B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
169.77MCNYFY2025 · Dec 31, 2025
52-Week Low
5.09CNYUpdated Oct 23, 2026
52-Week High
12.20CNYUpdated Oct 23, 2026
52-Week Change
-6.33%
vs all stocks
Updated Oct 23, 2026
Beta
0.2490x
vs all stocks
Updated Oct 23, 2026
50-Day MA
5.95CNYUpdated Oct 23, 2026
200-Day MA
7.05CNYUpdated Oct 23, 2026
Avg 10-Day Volume
37.42MSharesUpdated Oct 23, 2026
Avg 30-Day Volume
53.52MSharesUpdated Oct 23, 2026
Diluted EPS (TTM)
-0.1300CNYUpdated Oct 23, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Where is this company structurally exposed?
Within or Near the Altman Distress Zone
Debt is a large share of its assets, and large against its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.42Profit Margin: -0.08
Looks liquid, but the distress score says otherwiseNotable
Current Ratio: 2.04Altman Z-Score: 0.58
Financial Health
Altman Z-Score 0.58: distress zoneCritical
Altman Z-Score: 0.58
Supply Chain
Upstream position: supplies 5 industries, depends on 3Notable
Outgoing: 5.00Incoming: 3.00
Scale
Market cap is $1.58B, above the global median of $1.14BNotable
Market cap (USD): 1,575,091,901.283Global Median: 1,137,180,293.291
Levered free cash flow is $110.37M, above the global median of $18.58MNotable